Provided by Tiger Trade Technology Pte. Ltd.

CONSUN PHARMA

13.790
-1.140-7.64%
Volume:5.03M
Turnover:70.30M
Market Cap:11.57B
PE:9.38
High:14.930
Open:14.930
Low:13.710
Close:14.930
52wk High:18.949
52wk Low:12.310
Shares:839.00M
HK Float Shares:839.00M
Volume Ratio:1.59
T/O Rate:0.60%
Dividend:0.77
Dividend Rate:5.55%
EPS(LYR):1.470
ROE:23.60%
ROA:11.74%
PB:2.19
PE(LYR):9.38
PS:2.90

Loading ...

Concerns Surrounding Consun Pharmaceutical Group's (HKG:1681) Performance

Simply Wall St.
·
May 07

Consun Pharma Maintains 841.55 Million Issued Shares in April; Public Float Remains Compliant

Bulletin Express
·
May 04

CONSUN PHARMA (01681) Undergoing Valuation Rerating as It Builds Leading "Nephrology Flagship" Competitive Edge

Stock News
·
May 03

Consun Pharmaceutical publishes 2025 ESG report

Reuters
·
Apr 28

CONSUN PHARMA’s 2025 ESG Report: Lower Emissions, Strong R&D Pipeline and RMB 14.76 Billion Brand Valuation

Bulletin Express
·
Apr 28

康臣藥業2025年度業績速覽:收入增長15.2%至34.17億元,腎科板塊領跑業務

Bulletin Express
·
Apr 28

Consun Pharma Schedules 26 May 2026 AGM, Proposes HKD0.40 Final Dividend and New Share Mandates

Bulletin Express
·
Apr 28

ConSun Pharma Calls 26 May 2026 Hybrid AGM to Approve FY 2025 Results, HKD0.40 Final Dividend and New Share Mandates

Bulletin Express
·
Apr 28

Consun Pharmaceutical announces annual general meeting

Reuters
·
Apr 28

Strong Fundamentals and Inclusion in Stock Connect Create Key Investment Window for Consun Pharma (01681)

Stock News
·
Apr 07

CONSUN PHARMA Adds 124,000 Shares in March Through Option Exercise; Public Float Maintained

Bulletin Express
·
Apr 02

Consun Pharmaceutical Group (SEHK:1681) Earnings Growth And 31.5% Margins Challenge Valuation Skeptics

Simply Wall St.
·
Mar 28

BRIEF-Consun Pharmaceutical Logs FY Revenue RMB 3,420 Mln

Reuters
·
Mar 26

Consun Pharma to Distribute Final Dividend of HK$0.4 Per Share on June 22

Stock News
·
Mar 26

Consun Pharma Reports 18.41% Rise in Annual Profit Attributable to Shareholders

Stock News
·
Mar 26

Consun Pharmaceutical FY2025 final dividend proposed at HKD 0.4 per share

Reuters
·
Mar 26

Consun Pharmaceutical FY2025 profit attributable to equity shareholders climbs 18.4% to RMB1.08 billion; revenue grows 15.2% to RMB3.42 billion

Reuters
·
Mar 26

Consun Pharmaceutical Group Ltd - Final Dividend of HKD0.40 per Share

THOMSON REUTERS
·
Mar 26

Consun Pharmaceutical - Profit Attributable for Year RMB1.08 Bln

THOMSON REUTERS
·
Mar 26

Consun Pharmaceutical Group FY Revenue RMB 3,420 Million

THOMSON REUTERS
·
Mar 26